Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 243

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Depression in Parkinson's disease - a review

Open access
Lieberman, A. · 2006 · Acta Neurologica Scandinavica

Abstract

Major depression is present, at any given time, in 20-40% of Parkinson's disease (PD) patients, several times the prevalence in the general population. In addition, depression may precede the diagnosis of PD. These observations and reports of depression during deep brain stimulation of regions contiguous to the substantia nigra, as well as reports of dopamine agonist improving depression, suggest depression, rather than being mainly a psychological reaction to a debilitating disease, is part of PD. It is postulated that mesolimbic and mesocortical dopaminergic pathways that mediate affect, behavior, and cognition, contribute to depression in PD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-0404.2006.00536.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 79

  1. Leentjens AF, 2004, J Geriatric Psychiatry Neurol, 17, 120, 10.1177/0891988704267456 · DOI
  2. Ceravolo NA, 2004, Eur J Neurol, 11, 315, 10.1111/j.1468-1331.2004.00781.x · DOI · Paper page
  3. Burn DJ, 2002, Eur J Neurol, 9, 44, 10.1046/j.1468-1331.9.s3.6.x · DOI
  4. Zesiewicz TA, 2000, CNS Drugs, 13, 253, 10.2165/00023210-200013040-00003 · DOI
  5. Mayberg HS, 1995, Adv Neurol, 65, 49
  6. Brooks DJ, 2001, Curr Opin Neurol, 14, 465, 10.1097/00019052-200108000-00006 · DOI
  7. Cummings JL, 1992, Am J Psychiatry, 149, 443, 10.1176/ajp.149.4.443 · DOI · Paper page
  8. Oertel WH, 2001, Adv Neurol, 86, 373
  9. American Psychiatric Association, 1994, Statistical manual of mental disorders
  10. Edwards E, 2002, Depress Anxiety, 16, 39, 10.1002/da.10057 · DOI
  11. Lieberman AN, 1997, Barrow Neurol Inst Quart, 3, 27
  12. Hughes AJ, 1992, J Neurol Neurosurg Psychiatry, 55, 181, 10.1136/jnnp.55.3.181 · DOI · Paper page
  13. Hamilton M, 1967, Br J Soc Clin Psychol, 6, 278, 10.1111/j.2044-8260.1967.tb00530.x · DOI · Paper page
  14. 10.1002/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L · DOI · Paper page
  15. Lieberman AN, 2004, Medimond International Proceedings, 59
  16. Cummings JL, 1997, Neurology, 48, S10, 10.1212/WNL.48.5_Suppl_6.10S · DOI · Paper page
  17. 10.1176/appi.neuropsych.13.2.187 · doi:10.1176/appi.neuropsych.13.2.187 · Paper page
  18. Menza MA, 1994, J Neuropsychiatry Clin Neurosci, 6, 165, 10.1176/jnp.6.2.165 · DOI
  19. 10.1007/s007020050005 · DOI · Paper page
  20. 10.1034/j.1600-0447.2001.00372.x · doi:10.1034/j.1600-0447.2001.00372.x · Paper page
  21. 10.1034/j.1600-0447.2002.02229.x · DOI
  22. Leentjens AF, 2003, Mov Disord, 18, 414, 10.1002/mds.10387 · DOI · Paper page
  23. Richard IH, 1996, J Neuropsychiatry Clin Neurosci, 8, 383, 10.1176/jnp.8.4.383 · DOI · Paper page
  24. Rijk C, 1998, Ned Tijdschr Geneeskd, 142, 27
  25. 10.1002/mds.1099 · DOI · Paper page
  26. 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5 · DOI · Paper page
  27. Weisskopf MG, 2003, Mov Disord, 18, 646, 10.1002/mds.10425 · DOI
  28. 10.1002/mds.870080415 · DOI
  29. 10.1176/appi.neuropsych.13.1.35 · doi:10.1176/appi.neuropsych.13.1.35
  30. Raudino F, 2001, Acta Neurol Scand, 104, 312, 10.1034/j.1600-0404.2001.00357.x · DOI · Paper page
  31. Harding AJ, 2002, Brain, 125, 2431, 10.1093/brain/awf251 · DOI · Paper page
  32. Jelling KA, 2003, Acta Neuropathol (Berl), 106, 191, 10.1007/s00401-003-0725-y · DOI · Paper page
  33. 10.1002/gps.755 · DOI · Paper page
  34. 10.1136/jnnp.73.6.636 · DOI · Paper page
  35. Levy ML, 1998, J Neuropsychiatry Clin Neurosci, 10, 314, 10.1176/jnp.10.3.314 · DOI · Paper page
  36. Molina JA, 2000, Mov Disord, 15, 869, 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I · DOI · Paper page
  37. Driver-Dunckley E, 2003, Neurology, 61, 422, 10.1212/01.WNL.0000076478.45005.EC · DOI · Paper page
  38. Kurlan R, 2004, Mov Disord, 19, 433, 10.1002/mds.10625 · DOI
  39. 10.1136/jnnp.68.4.423 · DOI · Paper page
  40. 10.1016/S0165-0173(99)00023-5 · DOI · Paper page
  41. Willner P, 1994, Psychopharmacology (Berl), 115, 454, 10.1007/BF02245568 · DOI
  42. Hughes TA, 2000, Neurology, 54, 1596, 10.1212/WNL.54.8.1596 · DOI · Paper page
  43. Hobson P, 2004, Mov Disord, 19, 1043, 10.1002/mds.20216 · DOI · Paper page
  44. Lieberman A, 1997, Parkinsonism Relat Disord, 3, 151, 10.1016/S1353-8020(97)00017-5 · DOI
  45. Marsh L, 2004, Neurology, 63, 293, 10.1212/01.WNL.0000129843.15756.A3 · DOI · Paper page
  46. 10.1146/annurev.neuro.9.1.357 · doi:10.1146/annurev.neuro.9.1.357 · Paper page
  47. Happe S, 2001, Acta Neurol Scand, 104, 275, 10.1034/j.1600-0404.2001.00024.x · DOI
  48. Tandberg E, 1998, Mov Disord, 13, 895, 10.1002/mds.870130606 · DOI · Paper page
  49. Oerlemans WG, 2002, Sleep Med, 3, 147, 10.1016/S1389-9457(01)00127-7 · DOI
  50. Comella CL, 1998, Neurology, 51, 526, 10.1212/WNL.51.2.526 · DOI · Paper page
  51. Schenck CH, 1996, Neurology, 46, 388, 10.1212/WNL.46.2.388 · DOI · Paper page
  52. Torack RM, 1988, Arch Neurol, 45, 497, 10.1001/archneur.1988.00520290025008 · DOI · Paper page
  53. Mann JJ, 1995, Clin Neuropharmacol, 18, S57, 10.1097/00002826-199501001-00008 · DOI
  54. Willner P, 1997, Int Clin Psychopharmacol, 12, S7, 10.1097/00004850-199707003-00002 · DOI · Paper page
  55. Fahn S, 1971, J Neurol Sci, 14, 427, 10.1016/0022-510X(71)90178-X · DOI · Paper page
  56. 10.1002/cne.902870308 · DOI · Paper page
  57. Nagatsu T, 1984, Adv Neurol, 40, 467
  58. Anderson KE, 2003, Curr Neurol Neurosci Rep, 3, 306, 10.1007/s11910-003-0007-z · DOI
  59. 10.1056/NEJM199905133401905 · DOI · Paper page
  60. Funkieweiz A, 2001, Neurology, 56, 274
  61. 10.1023/A:1016806711705 · DOI
  62. Kopell BH, 2004, J Clin Neurophysiol, 21, 51, 10.1097/00004691-200401000-00007 · DOI · Paper page
  63. Laitinen LV, 1988, Appl Neurophysiol, 51, 317
  64. 10.1016/S0140-6736(02)11339-0 · DOI · Paper page
  65. 10.1086/379978 · DOI · Paper page
  66. Degner D, 2004, Pharmacopsychiatry, 37, S39, 10.1055/s-2004-815509 · DOI
  67. 10.1001/jama.284.15.1931 · DOI · Paper page
  68. Cummings JL, 1999, J Neurol Sci, 163, 2, 10.1016/S0022-510X(98)00306-2 · doi:10.1016/s0022-510x(98)00306-2
  69. 10.1046/j.1468-1331.2003.00612.x · DOI · Paper page
  70. Guttman M, 2001, Parkinsonism Relat Disord, 7, 231, 10.1016/S1353-8020(00)00062-6 · doi:10.1016/s1353-8020(00)00062-6
  71. Szegedi A, 1997, Clin Neuropharmacol, 20, S36, 10.1097/00002826-199720001-00006 · DOI
  72. 10.1023/A:1009060800999 · DOI
  73. 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H · doi:10.1002/(sici)1520-6394(2000)11:2<58::aid-da2>3.0.co;2-h
  74. 10.1002/mds.10566 · DOI
  75. Ritter JL, 1997, Ann Clin Psychiatry, 9, 7, 10.3109/10401239709147768 · DOI
  76. Richard IH, 1997, Neurology, 48, 1070, 10.1212/WNL.48.4.1070 · DOI · Paper page
  77. 10.1016/S1389-9457(03)00058-3 · DOI
  78. Hening WA, 2004, Sleep, 27, 560, 10.1093/sleep/27.3.560 · DOI · Paper page
  79. Adler CH, 2004, Neurology, 62, 1405, 10.1212/01.WNL.0000120672.94060.F1 · DOI

Cited by

See all 243

Metadata

Authors
Lieberman, A.
Venue
Acta Neurologica Scandinavica
Published
2006-01
Volume
113
Issue
1
Pages
1-8
ISSN
  • 0001-6314 (ISSN-L)
  • 1600-0404
OpenAlex
W2051737719
Cited by
243
References
8
FWCI
10.69
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1 (tdm, 3530 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.